Evidence map›Paper›PMID 33906325›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2021

New Trends of Cervical Cancer Incidence in Kazakhstan.

Nurbek Igissinov, Gulnur Igissinova, Zhansaya Telmanova, Zarina Bilyalova, Dariyana Kulmirzayeva, Zhanar Kozhakhmetova, Saltanat Urazova, Dulat Turebayev, Gaukhar Nurtazinova, Ardak Omarbekov and 9 more

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Vaccination Effectiveness against Human Papillomavirus in Kazakhstan.Asian Pacific journal of cancer prevention : APJCP · 2024
    Article
  9. Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends.Asian Pacific journal of cancer prevention : APJCP · 2023
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Nurbek IgissinovAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0002-2517-6315
Gulnur IgissinovaCentral Asian Cancer Institute, Nur-Sultan, Kazakhstan.ORCID 0000-0001-6881-2257
Zhansaya TelmanovaAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0002-2364-6520
Zarina BilyalovaCentral Asian Cancer Institute, Nur-Sultan, Kazakhstan.ORCID 0000-0002-0066-235X
Dariyana KulmirzayevaCentral Asian Cancer Institute, Nur-Sultan, Kazakhstan.
Zhanar KozhakhmetovaAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0002-7255-0955
Saltanat UrazovaAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0002-2331-1261
Dulat TurebayevAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0003-1557-3496
Gaukhar NurtazinovaAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0001-7314-0758
Ardak OmarbekovAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0003-2334-209X
Aigul AlmabayevaAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0002-5633-2245
Zhanar BukeyevaAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0003-2318-0625
Dinara TarzhanovaAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0002-3740-1874
Altyn MoldabayevaAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0002-3554-4978
Marina ZhanaliyevaAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0001-9393-4125
Ainagul KazbekovaAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0002-8300-2006
Vladimir OpenkoAstana Medical University, Nur-Sultan, Kazakhstan.
Saken KozhakhmetovAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0002-0075-0376
Yerlan KuandykovKhoja Akhmet Yassawi International Kazakh-Turkish University, Turkistan, Kazakhstan.ORCID 0000-0002-7966-1471

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe epidemiological features of the cervical cancer (CC) incidence and its spatial and temporal assessment in Kazakhstan were studied.

methodsThe retrospective study was done for the period 2009-2018. Descriptive and analytical methods of oncoepidemiology were used.

resultsDuring the study period, 16,441 new cases of CC were registered. The average annual crude and age-standardized incidence rate were 18.6±0.5 and 17.7±0.4 cases per 100,000 population of female, respectively, and their trends tended to increase (Тup=+2.3%; R2=0.708 and Тup=+1.9%; R2=0.615, respectively). The analysis of ASIR showed unimodal growth with a peak at 50-54 years - 45.3±1.1 cases per 100,000 population of female. Trends of ASIR decreased up to 30 years (Tdown=-1.8%; R2=0.111) and 35-59 years (Tdown=-0.9%; R2=0.103), in other age groups the trends increased, and were most pronounced in 40-44 (Тup=+4.1%; R2=0.878) and 65-69 years (Тup=+4.4%; R2=0.537). Trends in ASR of СС tended to grow in almost all regions, with higher levels in Mangystau (Тup=+4.1%; R2=0.482) and Aktobe (Тup=+6.3%; R2=0.846) regions. The cartograms of ASR per 100,000 population of female were allocated according to the following criteria: low - up to 16.3, average - from 16.3 to 19.2, high - above 19.2. The results of the spatial analysis showed the regions with a higher levels of CC incidence rate per 100,000 population of female: East Kazakhstan (19.8), Aktobe (20.0), Almaty (20.1), Kostanay region (20.9), Atyrau (21.7) regions and Almaty city (22.0).

conclusionThe study of trends of the cervical cancer incidence has the theoretical and practical value:  monitoring and evaluation of screening programmes, which are implemented in the country, and conduction of secondary prevention of cervical pathology. Health authorities should consider the obtained results in the in the organization of anti-cancer activities.

Indexed as

AdultAgedAged, 80 and overAge DistributionFemaleHumansIncidenceKazakhstanMiddle AgedRetrospective StudiesUterine Cervical NeoplasmsCervical cancerIncidenceKazakhstanTrends

Identifiers

PMID33906325
PMCPMC8325133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.